Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSULINFARCT: IV vs Subcutaneous Insulin in Acute Ischemic Stroke
NCT00472381Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2007
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in ischemic stroke (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Percentage of patients in the glucose target range (< 7 mmol/l) at 24 hours. Started May 2007; status: completed.
02
Drugs
human insulin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00472381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472381.